Abstract
Most of the digestion process in the living cell takes place in the lysosome. These organelles are formed in the trans Golgi network, from vesicles in which more than 40 different enzymes, mostly acid hydrolases, are selectively packed. The mature lysosome results from a fusion between these enzyme-containing vesicles and late endosomes where macromolecules awaiting disposal are entrapped. The acid pH maintained within the lysosome activates the enzymes such that proteins, nucleic acids and complex sugars are degraded. A deficiency in one of these digestive enzymes results in the toxic accumulation of its undegraded substrate. This ‘cellular dyspepsia’ (De Duve, 1964) results in a lysosomal storage which can severely impair the physiology of the cell.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anson, D.S., Bielicki, J. and Hopwood, J.J. (1992a) Correction of mucopolysaccharidosis type I fibroblasts by retroviral-mediated transfer of the human α-L-iduronidase gene Hum. Gene Ther., 3, 371–9.
Anson, D.S., Taylor, J.A., Bielicki, J. et al. (1992b) Correction of human mucopolysaccharidosis type-VI fibroblasts with recombinant N-acetylgalactosamine-4-sulphatase. Biochem. J., 284, 789–94.
Anson, D.S., Muller, V., Bielicki, J. et al. (1993) Overexpression of N-acetylgalactosamine-4-sulphatase induces a multiple sulphatase deficiency in mucopolysaccharidosis-type VI fibroblasts. Biochem. J., 294, 657–62.
Bajocchi, S.H., Feldman, S., Crystal, R. and Mastrangeli, A. (1993) Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nature Genet., 3, 229–34.
Bell, E., Ivarsson, B. and Merrill, C. (1979) Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc. Natl Acad. Sci. USA, 76, 1274–8.
Bielicki, J., Hopwood, J.J., Wilson, P. and Anson, D. (1993) Recombinant human iduronate-2-sulphatase: correction of mucopolysaccharidosis-type II fibroblasts and characterization of the purified enzyme. Biochem. J., 289, 241–6.
Birkenmeier, E.H., Davisson, M.T., Beamer, W.G. et al. (1989) Murine mucopolysaccharidosis type VII. Characterization of a mouse with β-glucuronidase deficiency. J. Clin. Invest., 83, 1258–66.
Birkenmeier, E.H., Barker, J.E., Vogler, C.A. et al. (1991) Increased life span and correction of metabolic defects in murine MPS VII following syngeneic bone marrow transplantation. Blood, 78, 3081–92.
Bodine, D.M., Moritz, T., Donahue, R.E. et al. (1993) Long-term in vivo expression of a murine adenosine deaminase gene in rhesus monkey hematopoietic cells of multiple lineages after retroviral mediated gene transfer into CD34+ bone marrow cells. Blood, 82, 1975–80.
Braun, S.E., Aronovich, E.L., Anderson, R.A. et al. (1993) Metabolic correction and cross-correction of mucopolysaccharidosis type II (Hunter syndrome) by retroviral-mediated gene transfer and expression of human iduronate-2-sulfatase. Proc. Natl Acad. Sci. USA, 90, 11830–4.
Breakefield, X.O. (1993) Gene delivery into the brain using virus vectors. Nature Genet., 3, 187–8.
Bunge, S., Steglich, C., Zuther, C. et al. (1993) Iduronate-2-sulfatase gene mutations in 16 patients with mucopolysaccharidosis type II (Hunter syndrome). Hum. Mol. Genet., 2, 1871–5.
Cardoso, J.E., Branchereau, S., Prema Roy, J. et al. (1993) In situ retrovirus-mediated gene transfer into dog liver. Hum. Gene Ther., 4, 411–18.
Chao, H.H.J., Waheed, A., Pohlman, R. et al. (1990) Mannose-6-phosphate receptor dependent secretion of lysosomal enzymes. EMBO J., 9, 3507–13.
Clarke, L.A. and Scott, H.S. (1993) Two novel mutations causing mucopolysaccharidosis type I detected by single strand conformational analysis of the α-L-iduronidase gene. Hum. Mol. Genet., 2, 1311–12.
Dean, M.F., Stevens, R.L., Muir, H. et al. (1979) Enzyme replacement therapy by fibroblasts transplantation. J. Clin. Invest., 63, 138–45.
De Duve, C. (1964) From cytases to lysosomes. Fed. Proc., 23, 1045–9.
Dhawan, J., Pan, L.C., Pavlath, G.K. et al. (1991) Systemic delivery of human growth hormone by injection of genetically-modified myoblasts. Science, 254, 1509–12.
Di Ferrante, N., Nichols, B.L., Donnelly, P.V. et al. (1971) Induced degradation of glycosaminoglycans in Hurler’s and Hunter’s syndromes by plasma infusions. Proc. Natl Acad. Sci. USA, 68, 303–7.
Ferry, N., Duplessis, O., Houssin, D. et al. (1991) Retroviral-mediated gene transfer into hepatocytes in vivo. Proc. Natl Acad. Sci. USA, 88, 8377–81.
Fukuda, S., Tomatsu, S., Masue, M. et al. (1992) Mucopolysaccharidosis type IVa. N-acetylgalactosamine-6-sulfate sulfatase exonic point mutations in classical Morquio and mild cases. J. Clin. Invest., 90, 1049–53.
Gage, F.H., Kawaja, M.D. and Fisher, L.J. (1991) Genetically modified cells: applications for intracerebral grafting. Trends Neurosci., 14, 328–33.
Gasper, P.W., Thrall, M.A., Wenger, D.A. et al. (1984) Correction of feline aryl-sulfatase B deficiency (mucopolysaccharidosis VI) by bone marrow transplantation. Nature, 312, 467–9.
Haskins, M.E., Jezyk, P.F., Desnick, R.J. et al. (1979) Alpha-L-iduronidase deficiency in a cat: a model for mucopolysaccharidosis I. Pediatr. Res., 13, 1294–7.
Haskins, M.E., Desnick, R.J., DiFerrante, N. et al. (1984) Beta-glucuronidase deficiency in a dog: a model of mucopolysaccharidosis VII. Pediatr. Res., 18, 980–4.
Hoogerbrugge, P.M., Suzuki, K., Suzuki, K. et al. (1988) Donor-derived cells in the central nervous system of twitcher mice after bone marrow transplantation. Science, 239, 1035–8.
Hopwood, J.J. and Morris, C.P. (1990) The mucopolysaccharidoses: diagnosis, molecular genetics and treatment. Mol. Biol. Med., 7, 381–404.
Jezyk, P.F., Haskins, M.E., Patterson, D.F. et al. (1977) Mucopolysaccharidosis in a cat with aryl-sulfatase B deficiency: a model of Maroteaux-Lamy syndrome. Science, 198, 834–6.
Jiao, S., Gurevich, V. and Wolff, J.A. (1993) Long-term correction of rat model of Parkinson’s disease by gene therapy. Nature, 362, 450–3.
Jin, W.D., Desnick, R.J. and Schuchman, E.H. (1992) Mucopolysaccharidosis type VI: identification of three mutations in the arylsulfatase B gene of patients with the severe and mild phenotypes provides evidence for genetic heterogeneity. Am. J. Hum. Genet., 50, 795–800.
Karlsson, S. (1991) Treatment of genetic defects in hematopoietic cell function by gene transfer. Blood, 78, 2481–92.
Krivit, W., Pierpont, M.E., Ayaz, K. et al. (1984) Bone marrow transplantation in the Maroteaux-Lamy syndrome (Mucopolysaccharidosis VI). N. Engl. J. Med., 311, 1601–11.
Krivit, W., Shapiro, E., Hoogerbrugge, P.M. and Moser, H.W. (1992) State of the art review: bone marrow transplantation treatment for storage diseases. Bone Marrow Transplant., 10, 87–97.
Maréchal, V., Naffakh, N., Danos, O. and Heard, J.M. (1993) Disappearance of lysosomal storage in spleen and liver of mucopolysaccharidosis VII mice after transplantation of genetically-modified bone marrow cells. Blood, 82, 1358–65.
Morreau, H., Galjart, N.J., Gillemans, N. et al. (1989) Alternative splicing of β-galactosidase mRNA generates the classic lysosomal enzyme and a β-galactosidase-related protein. J. Biol. Chem., 264, 20655–63.
Moullier, P., Bohl, D., Heard, J.M. and Danos, O. (1993) Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically-modified skin fibroblasts. Nature Genet., 4, 154–9.
Naffakh, N., Pinset, C., Montarras, D. et al. (1994) Transplantation of adult-derived myoblasts in mice following gene transfer. Neuromusc. Disord., 3, 413–17.
Neufeld, E.F. and Muenzer, J. (1989) The mucopolysaccharidoses, in The Metabolie Basis of Inherited Disease, (eds C.R. Scriver, A.L. Beaudet, W.S. Sly and D. Valee), McGraw-Hill, New York, pp. 1565–87.
Neufeld, E.F., Lim, T.W. and Shapiro, L.J. (1977) Inherited disorders of lysosomal metabolism. Annu. Rev. Biochem., 44, 357–76.
Oshima, A., Kyle, J.W., Miller, R.D. et al. (1987) Cloning, sequencing, and expression of cDNA for human β-glucuronidase. Proc. Natl Acad. Sci. USA, 84, 685–9.
Palmer, T.D., Rosman, G.J., Osborne, W.R.A. and Miller, A.D. (1991) Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. Proc. Natl Acad. Sci. USA, 88, 1330–4.
Pardridge, W.M. (1988) Recent advances in blood-brain barrier transport. Annu. Rev. Pharmacol. Toxicol., 28, 25–39.
Peters, C., Schmidt, B., Rommerskirch, W. et al. (1990) Phylogenetic conservation of arylsulfatases. cDNA cloning and expression of human arylsulfatase B. J. Biol. Chem., 265, 3374–81.
Peters, C., Rommerskirch, W., Modaressi, S. and von Figura, K. (1991) Restoration of arylsulphatase B activity in human mucopolysaccharidosis-type-VI fibroblasts by retroviral-vector-mediated gene transfer. Biochem. J., 276, 499–504.
Pfeffer, S.R. (1991) Targeting of proteins to the lysosome Curr. Top. Microbiol. Immunol., 170, 43–63.
Robertson, D.A., Freeman, C., Morris, C.P. and Hopwood, J.J. (1992) A cDNA clone for human glucosamine-6-sulphatase reveals differences between arylsulphatases and non-arylsulphatases. Biochem. J., 288, 539–44.
Roessler, B.J., Allen, E.D., Wilson, J.M. et al. (1993) Adenoviral-mediated gene transfer to rabbit synovium in vivo. J. Clin. Invest., 92, 1085–92.
Sands, M.S., Barker, J.E., Vogler, C. et al. (1993) Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates. Lab. Invest., 68, 676–86.
Scharf mann, R., Axelrod, J. H. and Verma, I.M. (1991) Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. Proc. Natl Acad. Sci. USA, 88, 4626–30.
Scott, H.S., Anson, D.S., Osborn, A.M. et al. (1991) Human alpha-L-iduronidase: cDNA isolation and expression. Proc. Natl Acad. Sci. USA, 88, 9695–9.
Scott, H.S., Litjens, T., Nelson, P.V. et al. (1993) Identification of mutations in the α-L-iduronidase gene (IDUA) causing Hurler and Scheie syndromes. Am. J. Hum. Genet., 53, 973–86.
Shipley, J.M., Klinkenbreg, M., Wu, B.M. et al. (1993) Mutational analysis of a patient with mucopolysaccharidosis type VII, and identification of pseudogenes. Am. J. Hum. Genet., 52, 517–26.
Shull, R.M., Munger, R.J., Spellacy, E. et al. (1982) Canine α-L-iduronidase deficiency: a model of mucopolysaccharidosis I. Am. J. Pathol., 109, 244–8.
Shull, R.M., Hastings, N.E., Selcer, R.R. et al. (1987) Bone marrow transplantation in canine mucopolysaccharidosis I. J. Clin. Invest., 79, 435–43.
Shull, R.M., Kakkis, E.D., McEntee, M.F. et al. (1994) Enzyme replacement in a canine model of Hurler syndrome. Proc. Natl Acad. Sci. USA, 91, 12937–41.
Smith, B.F., Hoffman, R.K., Giger, U. and Wolfe, J.H. (1990) Genes transferred by retroviral vectors into normal and mutant myoblasts in primary cultures are expressed in myotubes. Mol. Cell. Biol., 10, 3268–71.
Snyder, E.Y., Deitcher, D.L., Walsh, C. et al. (1992) Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell, 68, 33–51.
Thompson, J.-N., Jones, M.Z., Dawson, G. and Huffman, P.S. (1992) N-acetyl-glucosamine 6-sulphatase deficiency in a Nubian goat: a model of Sanfilippo syndrome type D (mucopolysaccharidosis HID). J. Inherit. Metab. Dis., 15, 760–8.
Tomatsu, S., Fukuda, S., Masue, M. et al. (1991) Morquio disease: isolation, characterization and expression of full-length cDNA for human N-acetyl-galactosamine-6-sulfate sulfatase. Biochem. Biopbys. Res. Commun., 2, 677–83.
Vellodi, A., Young, E., New, M. et al. (1992) Bone marrow transplantation for Sanfilippo disease type B. J. Inher. Metab. Dis., 15, 911–18.
Vogler, C., Sands, M., Higgins, A. et al. (1993) Enzyme replacement with recombinant β-glucuronidase in the newborn mucopolysaccharidosis type VII mouse. Pediatr. Res., 34, 837–40.
Wilson, P.J., Morris, C.P., Anson, D.S. et al. (1990) Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA. Proc. Natl Acad. Sci. USA, 87, 8531–5.
Wilson, P.J., Suthers, G.K., Callen, D.F. et al. (1991) Frequent deletions at Xq28 indicate genetic hetrogeniety in Hunter syndrome. Hum. Genet., 86, 505–8.
Wolfe, J.H., Schuchman, E.H., Stramm, L.E. et al. (1990) Restoration of normal lysosomal function in mucopolysaccharidosis type VII cells by retroviral vector-mediated gene transfer. Proc. Natl Acad. Sci. USA, 87, 2877–81.
Wolfe, J.H., Deshmane, S.L. and Fraser, N.W. (1992a) Herpesvirus vector gene transfer and expression of β-glucuronidase in the central nervous system of MPS VII mice. Nature Genet., 1, 379–84.
Wolfe, J.H., Sands, M.S., Barker, J.E. et al. (1992b) Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer. Nature, 360, 749–53.
Yamada, Y., Tomatsu, S., Sukegawa, K. et al. (1993) Mucopolysaccharidosis type II (Hunter Disease): 13 mutations in 52 Japanese patients and carrier detection in four families. Hum. Genet., 92, 110 –14.
Yoshida, M., Noguchi, J., Ikadai, H. et al. (1993) Arylsulfatase B-deficient mucopolysaccharidosis in rats. J. Clin. Invest., 91, 1099–104.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Danos, O., Heard, JM. (1995). Mucopolysaccharidosis. In: Dickson, G. (eds) Molecular and Cell Biology of Human Gene Therapeutics. Molecular and Cell Biology of Human Diseases Series, vol 20. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-0547-7_17
Download citation
DOI: https://doi.org/10.1007/978-94-011-0547-7_17
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-4242-0
Online ISBN: 978-94-011-0547-7
eBook Packages: Springer Book Archive